New research shows promise for Phase 2/3 trial of inhaled insulin in people with MCI or mid Alzheimer’s disease – Alzheimer’s Society comment
Phase 2/3 clinical trial results shows early promise for an inhaled insulin spray in people with mild cognitive impairment (MCI) or mild Alzheimer’s disease.